Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes.
Current Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of drug targets. The journal also accepts for publication full-length/mini review articles and drug clinical trial studies.
As the discovery, identification, characterization and validation of novel human drug targets for drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

Current Drug Therapy publishes high-quality original research articles, full-length/mini reviews, and guest-edited thematic issues covering a wide range of topics in drug science, therapy, and medical advancements. The journal encompasses research on:

• Drug discovery, development, and delivery
• Clinical trials and real-world evidence studies
• Pharmacology, toxicology, and drug safety
• Targeted and biologic therapies, including immunotherapy
• Traditional, alternative, and regenerative medicine
• Personalized medicine, pharmacogenomics, and precision therapies
• Artificial intelligence and big data in drug research
• Regulatory science, drug approval processes, and public health perspectives
• Vaccine development, immunization strategies, and epidemiology
• Drug repurposing, repositioning, and novel therapeutic approaches
• Nanotechnology in Drug Delivery
• Gene and Cell Therapies
• Antimicrobial Resistance and Novel Antibiotics
• Neuropharmacology and Psychiatric Drug Development
•  Pediatric and Geriatric Pharmacology

The journal serves as an essential resource for researchers, clinicians, and industry professionals working in drug science, healthcare, and therapeutic innovations.
Current Drug Therapy is an international, peer-reviewed journal on all the latest advances in drug therapy and drug clinical trial studies, published monthly (print & online) by Bentham Science Publishers.

Current Enzyme Inhibition aims to publish all the latest and outstanding developments in enzyme inhibition studies with regards to the mechanisms of inhibitory processes of enzymes, recognition of active sites, and the discovery of agonists and antagonists, leading to the design and development of new drugs of significant therapeutic value. Each issue contains a series of timely, in-depth reviews written by leaders in the field, covering a range of enzymes that can be exploited for drug development. Current Enzyme Inhibition is an essential journal for every pharmaceutical and medicinal chemist who wishes to have up-to-date knowledge about each and every development in the study of enzyme inhibition.

Current Functional Foods aims to publish cutting-edge research in the field of foods and food ingredients with health benefits.
The journal focuses on functional foods with an emphasis on food chemistry, food technology, nutrition, and health. Reviews and research papers with an interdisciplinary approach are welcomed. The journal covers the fields of bioactive plants used for nutrition, dietary fiber, probiotics; functional lipids; bioactive peptides; vitamins, minerals and botanicals, and other dietary supplements. Experimental works dealing with food digestion, bioavailability of food bioactives and the mechanisms by which foods and their components are able to modulate physiological parameters connected with disease prevention of dysmetabolism will be considered for publication. The areas covered include new food bioactives, efficacy and toxicology of bioactive compounds, and other healthy food constituents. The use of genomic, chemical, and biochemical technologies for the study of such materials is included. Various aspects of technology and research on food science that include processing of food, hydrocolloids, cereals, additives and contaminants of food, food chemistry and microbiology, are also covered in the scope of this journal.
Characterization of healthy foods and functional constituents with reference to product development; preparation of natural and synthetic ingredients for use in foods, effects of processing (including packaging and storage) on functionality and improvement of product quality; verification, quality control, and traceability of natural and synthetic functional food ingredients and products will be considered. Contributions covering the regulatory aspects of functional foods and related issues e.g. labelling and substantiation of health claims value creation in food chains based on nutritional and health aspects of the food chain are also welcome.

Current HIV Research covers all the latest and outstanding developments in HIV and viral immune diseases research by publishing original research, full-length/mini-review articles, and guest-edited thematic issues. The novel pioneering work in the basic and clinical fields on all areas of HIV and viral immune diseases research covers virus replication and gene expression, HIV assembly, virus-cell interaction, viral pathogenesis, epidemiology and transmission, anti-retroviral therapy and adherence, drug discovery, the latest developments in HIV/AIDS vaccines and animal models, mechanisms and interactions with AIDS-related diseases, social and public health issues related to HIV disease, and prevention of viral infection. Periodically, the journal invites guest editors to devote an issue on a particular area of HIV research and viral immune diseases of great interest that increases our understanding of the viruses and their complex interaction with the host. All aspects of viral diseases, including Coronavirus, will be covered.
Current HIV Research is an international, peer-reviewed journal on all aspects of HIV and viral immune diseases, published bi-monthly (print and online) by Bentham Science Publishers.